M&T Bank
NXTC icon

M&T Bank’s NextCure NXTC Stock Holding History

M&T Bank’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-345
Closed -$233K – 1659
2019
Q4 		$233K Buy
+345
New +$173K ﹤0.01% 1198

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

M&T Bank's NXTC Position: Q1 2020 in Review

M&T Bank sold out of NextCure (NXTC) in Q1 2020, closing a stake of 345 shares — an estimated $233K sold.

M&T Bank first reported a position in NXTC in Q4 2019 and held it in 1 quarter. The position peaked at $233K in Q4 2019. 82 funds tracked by Wall St. Rank hold NXTC as of Q1 2020.

  • M&T Bank reported no remaining NextCure position as of Q1 2020 after selling out during the quarter.
  • M&T Bank sold 345 NextCure shares in Q1 2020, an estimated $233K.
  • M&T Bank first reported a position in NextCure in Q4 2019 and held it in 1 quarter.
  • M&T Bank's NextCure position peaked at $233K in Q4 2019.
  • 82 funds tracked by Wall St. Rank held NextCure as of Q1 2020.

Based on M&T Bank's 13F filing for Q1 2020, filed 14 May 2020.